Product Information
PHENOBARBITAL 32.4 MG TABLET is a generic product labeled by Trigen Laboratories, LLC, priced at $0.0732 per EA under NDC 13811030552. Its NADAC has been published 42 times since Nov 5, 2025.
Strength
32.4 mg/1
Manufacturer
Trigen Laboratories, LLCNDC
13811030552
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PHENOBARBITALApproval Type
Unapproved
On Market Since
4/1/2025
Price Statistics
The NADAC for PHENOBARBITAL 32.4 MG TABLET has been published 42 times since Nov 5, 2025, and over the history we have for it it has declined 48.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0732 per EA |
|---|---|
| All-time high | $0.1423 (Nov 12, 2025) |
| All-time low | $0.0732 (Jul 22, 2026) |
| 52-week high | $0.1423 |
| 52-week low | $0.0732 |
| Median price | $0.0879 |
| Average price | $0.0968 |
| Largest weekly change | -24.0% (Jan 21, 2026) |
| Weeks tracked | 42 |
| Tracking since | Nov 5, 2025 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PHENOBARBITAL 32.4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PHENOBARBITAL 32.4 MG TABLET, manufactured by Trigen Laboratories, LLC, is $0.0732 per EA (NDC 13811030552), effective Aug 19, 2026.
How has the price of PHENOBARBITAL 32.4 MG TABLET changed over time?
Over the history we have for it, the NADAC for PHENOBARBITAL 32.4 MG TABLET has declined 48.6%. It has been tracked across 42 weekly CMS publications since Nov 5, 2025.
What are the highest and lowest recorded NADAC prices for PHENOBARBITAL 32.4 MG TABLET?
Since Nov 5, 2025, the NADAC for PHENOBARBITAL 32.4 MG TABLET has ranged from a low of $0.0732 (Jul 22, 2026) to a high of $0.1423 (Nov 12, 2025), with a median of $0.0879 per EA.
Are there cheaper alternatives to PHENOBARBITAL 32.4 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PHENOBARBITAL 32.4 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PHENOBARBITAL 32.4 MG TABLET?
PHENOBARBITAL 32.4 MG TABLET (NDC 13811030552) is labeled by Trigen Laboratories, LLC, and CMS classifies it as a generic product.